Drug intelligence / Profile preview

Qing-Hua-Bu therapy

Development stage
Unknown
Lead developer
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
Modality
Small Molecules
Administration
Topical
01

Overview

"Qing-Hua-Bu" is a three-stage dynamic sequential external Traditional Chinese Medicine (TCM) therapy developed by Shanghai Yueyang Integrated Medicine Hospital for the treatment of diabetic ulcers. The therapy is based on the sequential application of different herbal formulations tailored to the wound's healing stage: "Qing" (clearing heat and dampness) for the inflammatory stage, "Hua" (activating blood and resolving stasis) for the proliferative stage, and "Bu" (tonifying deficiency and promoting granulation) for the remodeling stage. This approach follows the TCM principle of "Remove slough-Eliminate stasis-Generate granulation tissue." The therapy is administered topically and has been evaluated in a Phase 2 clinical trial (NCT03574935) to assess its efficacy and safety compared to standard Western external treatments.

Other names
Qing-Hua-Bu three-stage dynamic sequential therapyRemove slough-Eliminate stasis-Generate granulation tissue therapy
02

Targets

CCR5 (C-C chemokine receptor type 5)GM-CSF (Granulocyte-macrophage colony-stimulating factor)IL8 (C-X-C Motif Chemokine Ligand 8)IFNG (Interferon gamma)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)

Beyond the preview

Go deeper on Qing-Hua-Bu therapy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qing-Hua-Bu therapy.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call